Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Astria Therapeutics, Inc. (ATXS)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K/A | 10-K | 10-K | 10-K | 10-K |
| Revenues | | | | | | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | | | | | | 0.0% | 100.0% | 100.0% |
| Gross profit | | | | | | 100.0% | 0.0% | 0.0% |
| Research and development | | | | | | 3736.4% | 6768.6% | 23030.0% |
| General and administrative | | | | | | 1782.4% | 2688.3% | 8629.0% |
| Depreciation | | | | | | 60.8% | 105.1% | 202.0% |
| EBIT | | | | | | -5418.8% | -9456.9% | -31659.0% |
| Pre-tax income | | | | | | -5472.8% | -9590.4% | -32630.0% |
| Income taxes | | | | | | 0.0% | 0.0% | 0.0% |
| Net income | | | | | | -5472.8% | -9590.4% | -32630.0% |
|